EMA publishes agenda for 13-16 September CHMP meeting

EMA

13 September 2021 - The EMA has published a draft agenda for this week's CHMP meeting.

The CHMP is due to issue opinions for the following technologies:

  • Artesunate
  • Zanubrutinib
  • Adalimumab
  • Pegcetacoplan
  • Ripretinib
  • Tanezumab
  • Lasmiditan
  • Rivaroxaban
  • Sugammadex
  • Glucarpidase
  • Diroximel fumarate

Read CHMP agenda

Michael Wonder

Posted by:

Michael Wonder